Aleš Imramovský

1.5k total citations
65 papers, 1.2k citations indexed

About

Aleš Imramovský is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Aleš Imramovský has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Organic Chemistry, 23 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Aleš Imramovský's work include Synthesis and biological activity (18 papers), Cancer therapeutics and mechanisms (9 papers) and Fungal Plant Pathogen Control (7 papers). Aleš Imramovský is often cited by papers focused on Synthesis and biological activity (18 papers), Cancer therapeutics and mechanisms (9 papers) and Fungal Plant Pathogen Control (7 papers). Aleš Imramovský collaborates with scholars based in Czechia, Slovakia and Poland. Aleš Imramovský's co-authors include Josef Jampílek, Jarmila Vinšová, Karel Pauk, Jarmila Kaustová, Alois Čížek, Iveta Zadražilová, Matúš Peško, Katarína Kráľová, Péter Kollár and Marijan Kočevar and has published in prestigious journals such as International Journal of Molecular Sciences, Chemistry - A European Journal and Molecules.

In The Last Decade

Aleš Imramovský

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aleš Imramovský Czechia 21 705 442 191 144 127 65 1.2k
Mohd. Zaheen Hassan Saudi Arabia 23 1.1k 1.5× 398 0.9× 191 1.0× 143 1.0× 68 0.5× 75 1.7k
Alessandra Mendonça Teles de Souza Brazil 22 952 1.4× 361 0.8× 116 0.6× 92 0.6× 148 1.2× 65 1.6k
M. K. Kathiravan India 17 826 1.2× 545 1.2× 181 0.9× 161 1.1× 230 1.8× 98 1.7k
Joazaizulfazli Jamalis Malaysia 23 710 1.0× 418 0.9× 137 0.7× 265 1.8× 76 0.6× 81 1.4k
İlkay Küçükgüzel Türkiye 22 1.2k 1.8× 360 0.8× 223 1.2× 135 0.9× 111 0.9× 57 1.7k
Federico Berti Italy 24 650 0.9× 857 1.9× 129 0.7× 80 0.6× 143 1.1× 105 1.8k
Elizabeth Igne Ferreira Brazil 22 539 0.8× 486 1.1× 96 0.5× 196 1.4× 128 1.0× 77 1.4k
Indresh Kumar Maurya India 19 433 0.6× 360 0.8× 111 0.6× 86 0.6× 137 1.1× 46 1.2k
Hakan Göker Türkiye 22 1.3k 1.9× 475 1.1× 138 0.7× 114 0.8× 57 0.4× 77 1.6k
Francisco Hernández‐Luis Mexico 23 962 1.4× 337 0.8× 92 0.5× 149 1.0× 121 1.0× 53 1.6k

Countries citing papers authored by Aleš Imramovský

Since Specialization
Citations

This map shows the geographic impact of Aleš Imramovský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleš Imramovský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleš Imramovský more than expected).

Fields of papers citing papers by Aleš Imramovský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleš Imramovský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleš Imramovský. The network helps show where Aleš Imramovský may publish in the future.

Co-authorship network of co-authors of Aleš Imramovský

This figure shows the co-authorship network connecting the top 25 collaborators of Aleš Imramovský. A scholar is included among the top collaborators of Aleš Imramovský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleš Imramovský. Aleš Imramovský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pauk, Karel, Aleš Imramovský, Dawid Zych, et al.. (2025). Fluorescent properties and bioimaging potential of phenyl-substituted symmetrical furan diketopyrrolopyrroles. Dyes and Pigments. 238. 112700–112700. 1 indexed citations
3.
Jorda, Radek, et al.. (2020). Novel modified leucine and phenylalanine dipeptides modulate viability and attachment of cancer cells. European Journal of Medicinal Chemistry. 188. 112036–112036. 13 indexed citations
4.
Bąk, Andrzej, Violetta Kozik, Aleš Imramovský, et al.. (2019). Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study. International Journal of Molecular Sciences. 20(7). 1524–1524. 17 indexed citations
5.
Jorda, Radek, Ján Dušek, Eva Řezníčková, et al.. (2017). Synthesis and antiproteasomal activity of novel O -benzyl salicylamide-based inhibitors built from leucine and phenylalanine. European Journal of Medicinal Chemistry. 135. 142–158. 6 indexed citations
7.
Imramovský, Aleš, et al.. (2015). Aminolysis of ezetimibe. Journal of Pharmaceutical and Biomedical Analysis. 107. 495–500. 2 indexed citations
8.
Imramovský, Aleš, et al.. (2014). Kinetics and Mechanism of the Base-Catalyzed Rearrangement and Hydrolysis of Ezetimibe. Journal of Pharmaceutical Sciences. 103(8). 2240–2247. 8 indexed citations
9.
Sedlák, Miloš, et al.. (2013). Synthesis and characterization of a pH-sensitive conjugate of isoniazid with Fe3O4@SiO2 magnetic nanoparticles. Bioorganic & Medicinal Chemistry Letters. 23(16). 4692–4695. 14 indexed citations
10.
Imramovský, Aleš, Radek Jorda, Karel Pauk, et al.. (2013). Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines. European Journal of Medicinal Chemistry. 68. 253–259. 26 indexed citations
11.
Pauk, Karel, Iveta Zadražilová, Aleš Imramovský, et al.. (2013). New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species. Bioorganic & Medicinal Chemistry. 21(21). 6574–6581. 51 indexed citations
12.
Vinšová, Jarmila, et al.. (2012). Antistaphylococcal Activity of Novel Salicylanilide Derivatives. Current Drug Discovery Technologies. 9(1). 39–47. 2 indexed citations
13.
Abdel-Mohsen, A.M., Rasha M. Abdel-Rahman, Radim Hrdina, et al.. (2012). Antibacterial cotton fabrics treated with core–shell nanoparticles. International Journal of Biological Macromolecules. 50(5). 1245–1253. 64 indexed citations
14.
Imramovský, Aleš, et al.. (2012). Synthesis and characterization of pH-sensitive conjugate of isoniazid – methoxypoly(ethylene glycol)-b-poly(l-lysine). Bioorganic & Medicinal Chemistry Letters. 22(18). 5952–5955. 2 indexed citations
15.
Vavříková, Eva, Slovenko Polanc, Marijan Kočevar, et al.. (2011). New series of isoniazid hydrazones linked with electron-withdrawing substituents. European Journal of Medicinal Chemistry. 46(12). 5902–5909. 38 indexed citations
16.
Imramovský, Aleš, et al.. (2011). Photosynthesis—Inhibiting efficiency of 4-chloro-2-(chlorophenylcarbamoyl)phenyl alkylcarbamates. Bioorganic & Medicinal Chemistry Letters. 21(15). 4564–4567. 38 indexed citations
17.
Imramovský, Aleš, et al.. (2011). Recent Advances in the Design and Synthesis of Prednisolone and Methylprednisolone Conjugates. Current Pharmaceutical Design. 17(32). 3577–3595. 8 indexed citations
18.
Sedlák, Miloš, et al.. (2011). Prednisolone-α-cyclodextrin-star poly(ethylene glycol) polypseudorotaxane with delayed pH-sensitivity as a targeted drug delivery system. International Journal of Pharmaceutics. 414(1-2). 42–47. 15 indexed citations
19.
Imramovský, Aleš, et al.. (2009). New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains. Bioorganic & Medicinal Chemistry. 17(10). 3572–3579. 43 indexed citations
20.
Imramovský, Aleš, et al.. (2008). Salicylanilide esters of N-protected amino acids as novel antimicrobial agents. Bioorganic & Medicinal Chemistry Letters. 19(2). 348–351. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026